Need for Artificial Intelligence in Pharmaceutical Industry and its Limitations
Received Date: Jun 30, 2022 / Published Date: Jul 29, 2022
Abstract
AI is often being touted as the means to bring about the fourth Industrial Revolution and its role in almost all sectors of our society is almost certain. This brings about an urgent need for evaluating benefits and limitations of AI and machine learning across various sectors. Pharmaceutical industry has pioneered in embracing the use of AI in all of its core areas but the success as of yet seems very limited. The major advantage of AI is that it reduces the time that is needed for drug development and, in turn, it reduces the costs that are associated with drug development, enhances the returns on investment and may even cause a decrease in cost for the end user along with improved drug safety. So in this article we will review the scope and limitations of AI in the pharmaceutical industry.
Citation: Pareek V, Sharma L, Kumar S (2022) Need for Artificial Intelligence in Pharmaceutical Industry and its Limitations. World J Pharmacol Toxicol 5: 161. Doi: 10.4172/wjpt.1000161
Copyright: © 2022 Pareek V, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
天美传媒 Access Journals
Article Tools
Article Usage
- Total views: 1755
- [From(publication date): 0-2022 - Jan 10, 2025]
- Breakdown by view type
- HTML page views: 1554
- PDF downloads: 201
